Examples of such statements include statements about the potential benefits of the Magellan Robotic System on vascular procedures, expectations of shipments of our Magellan Robotic System, the company’s ability to improve margins, lower expenses and improve cash burn and the sufficiency of the company’s cash resources for supporting the initial launch of the Magellan Robotic System.
Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, among others, engineering, regulatory, manufacturing, sales and customer service challenges in developing new products and entering new markets; potential safety and regulatory issues that could slow or suspend our sales; the effect of credit, financial and economic condition on capital spending by our potential customers, the uncertain timelines for the sales cycle of newly introduced products, the rate of adoption of our systems and the rate of use of our catheters, the scope and validity of intellectual property rights applicable to our products, competition from other companies, our ability to maintain our remedial actions over previous reported material weaknesses and internal control over financial reporting, our ability to manage expenses and cash flow and obtain additional financing and other risks more fully described in the Risk Factors section of our quarterly report on Form 10-Q for the quarter ended March 31, 2012 filed with the SEC on May 07, 2012, and the risks discussed in our other reports filed with the SEC.
Given these uncertainties, you should not place undue reliance on the forward-looking statements included in our remarks in responses to questions. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future even if new information becomes available.
In addition, today’s call includes comments from an invited physician speaker, and his comments also contain forward-looking statements that are subject to risks and uncertainties. The comments of the speaker are his own and should not be attributed to the company.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts